Lactase and application thereof in fresh milk lactose in-situ conversion
By mutation of the T446 and R457 sites of the lactase BcBG168-D, the obtained lactase mutant T446L-R457P improved the conversion efficiency of lactose at lower temperatures and quickly inactivated under high temperature treatment, solving the existing lactose The low efficiency of enzyme transglycoside efficiency and poor thermal stability of enzymes in fresh milk have achieved efficient lactose conversion and nutritional value improvement.
Patent Information
- Application Number
- CN202410957962.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-17
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-07-17
AI Technical Summary
The existing lactases have low transglycoside efficiency at lower temperatures and are difficult to inactivate after heat treatment, which limits their application in fresh milk and the production of low-lactose dairy products.
By directed evolution of Bacillus cyclic Bacillus lactase BcBG168-D, two-point mutations at the T446 and R457 sites were carried out to obtain the lactase mutant T446L-R457P, which improves its conversion efficiency at lower temperatures and at subsequent high temperatures Quickly inactivated under treatment.
The lactase mutant T446L-R457P significantly increased the conversion rate of lactose at 55℃, reaching 82.16%, and was completely inactivated at 62.8℃, meeting the production needs of low-lactose dairy products and enhancing the nutritional value of fresh milk.
Smart Images

Figure CN119060989A_ABST
Abstract
Description
Technical field:
[0001] The invention belongs to the technical field of enzyme engineering and food engineering, and specifically relates to directed evolution and site-directed mutation of lactase enzyme molecules and application thereof in fresh milk. Background technology:
[0002] Dairy products refer to various liquid or solid foods made from milk as the main raw material through heating, drying, freezing or fermentation. Dairy products provide comprehensive and balanced nutrients for human health and growth and development. They not only provide a variety of carbohydrates, but also high-quality proteins, calcium and vitamins. Dairy products have become an indispensable food in human life. Every day, 6 billion people around the world consume dairy products, accounting for about 10% of daily energy intake.
[0003] Lactose in dairy products can cause abdominal pain, bloating, flatulence and diarrhea. 70% of adults worldwide have varying degrees of lactose intolerance, which greatly limits people's intake and consumption of dairy products. Therefore, removing lactose from dairy products has become a problem that the dairy industry must solve. The lactose content in low-lactose products must be less than 2g / 100g, and the lactose content in lactose-free products must be less than 0.5g / 100g. There are usually two methods to remove lactose from dairy products. One is membrane filtration, which uses microfiltration membranes, ultrafiltration membranes and other equipment to remove lactose from dairy products to obtain low-lactose or lactose-free dairy products; the other is enzymatic conversion, which uses the hydrolytic activity of lactase (a type of β-galactosidase, EC 3.2.1.23) to hydrolyze lactose into glucose and galactose. On the other hand, lactase with transaside activity can catalyze the transaside of lactose to form galactooligosaccharides (GOS), that is, the transaside characteristics of lactase are used to convert lactose into GOS with better functional value. Lactase used for lactose hydrolysis mainly comes from Kluyveromyces fragilis, Kluyveromyces fragilis, Aspergillus niger and Aspergillus oryzae. Among them, the lactase from Kluyveromyces sp. is a neutral lactase, which is mainly used for the hydrolysis of lactose in liquid dairy products; the lactase from Aspergillus sp. is mostly acidic lactase, which is mainly used as a nutritional supplement and cannot be directly applied to the direct enzymatic hydrolysis of lactose in fresh milk.
[0004] Galacto-oligosaccharide is a functional oligosaccharide naturally present in human milk, cow's milk and goat's milk. It has mild sweetness and sensory properties. It can be used as a partial substitute for fat and sugar in food and improves food texture, but it is not digested by human intestinal enzymes and reaches the large intestine. As a growth factor, it promotes the proliferation of beneficial bacteria such as bifidobacteria and lactobacilli, enhances mineral absorption, reduces blood lipids, cholesterol and glycemic index, improves blood pressure, and has a beneficial effect on human health. The existing lactase for producing galacto-oligosaccharide mainly comes from Bacillus circulans, and there is also an enzyme preparation from Aspergillus oryzae, but the transglycoside efficiency is low. Therefore, at present, Bacillus circulans lactase is the best enzyme preparation currently used for efficient preparation of GOS enzymatic method. For example, previous studies have found that the lactase identified from Bacillus circulans B2301 has the ability to catalyze lactose to form 54.5% GOS under high temperature conditions above 60°C, making it the lactase with the best GOS synthesis performance among all reported lactases (Zhao Jihua et al., Food and Fermentation Industries, 2020); the expression level of lactase BcBG168-D prepared by fermentation of high-lactase Bacillus licheniformis BCBTBc168D also has good application value (Chinese invention patent, ZL202011051056.1).
[0005] However, if Bacillus circulans lactase is directly applied to fresh milk, lactose in fresh milk is directly bioconverted, and lactose therein is converted into GOS in situ, it is necessary to solve the problem of high efficiency of transglycosidation of the enzyme at a lower temperature and convenience of inactivation of the enzyme after transglycosidation. To this end, the present invention mutates specific amino acid sites of Bacillus circulans B2301 lactase BcBG168-D (Wang Zhengxiang, Niu Dandan, Tian Kangming. Chinese invention patent, ZL202011051056.1) according to fresh milk processing requirements and processing characteristics, in order to obtain a new enzyme molecule that can efficiently convert lactose into GOS at a lower temperature, and can simultaneously meet the requirements of subsequent heat treatment (such as pasteurization) and can be quickly inactivated, so as to realize its application in low-lactose dairy products, which has important application significance for improving the nutritional value of fresh milk and the universality of consumers. Summary of the invention:
[0006] Through the directed artificial evolution of lactase molecules, we obtained new lactase molecules that can efficiently convert lactose in fresh milk at low temperatures and synthesize galacto-oligosaccharides at the same time, and quickly inactivate at subsequent elevated temperatures (such as pasteurization). This is beneficial to the highly nutritious in situ bioconversion of lactose in fresh milk into prebiotic galacto-oligosaccharides, which can further enhance the nutritional value of fresh milk and expand the fresh milk consumer group.
[0007] In order to achieve the above-mentioned object, the present invention is based on the lactase BcBG168-D encoding gene (the nucleotide sequence shown in the sequence list SEQ ID NO.1) or its amino acid sequence (shown in the sequence list SEQ ID NO.2), obtains a low-temperature high-activity mutant through site-directed mutagenesis and screening, analyzes and evaluates its enzymatic application performance through the expression and preparation of the mutant, and evaluates its application value in fresh milk.
[0008] One of the technical solutions provided by the present invention is a lactase mutant, wherein the lactase mutant is obtained by causing double point mutations of amino acid residues T446 and R457 in the amino acid sequence of the lactase shown in SEQ ID NO.2;
[0009] Furthermore, the lactase mutant is obtained by causing T446L and R457P mutations to the lactase shown in SEQ ID NO.2, and is named mutant T446L-R457P, and the amino acid sequence is shown in SEQ ID NO.4.
[0010] The second technical solution provided by the present invention is the coding gene of the above-mentioned lactase mutant T446L-R457P;
[0011] Furthermore, the nucleotide sequence of the gene encoding the mutant T446L-R457P is shown in SEQ ID NO.3.
[0012] The third technical solution provided by the present invention is a recombinant vector or recombinant strain comprising the gene encoding the lactase mutant T446L-R457P;
[0013] Furthermore, the expression vector used in the recombinant vector is pHY-WZX plasmid;
[0014] Furthermore, the host of the recombinant strain is Bacillus licheniformis BCBT0529 (published in Chinese invention patent ZL202011051056.1);
[0015] Furthermore, the recombinant strain is obtained by cloning the lactase mutant encoding gene shown in SEQ ID NO.3 into the expression vector pHY-WZX and performing recombinant expression in the Bacillus licheniformis BCBT0529 host cell.
[0016] The fourth technical solution provided by the present invention is the application of the above-mentioned recombinant vector or recombinant strain, especially the application in producing the lactase mutant T446L-R457P described in the first technical solution.
[0017] The fifth technical solution provided by the present invention is the application of the lactase mutant T446L-R457P described in the first technical solution, especially the application in catalyzing lactose to produce galacto-oligosaccharides, and more particularly the application in producing low-lactose dairy products containing galacto-oligosaccharides;
[0018] Furthermore, the invention is used for in-situ conversion of lactose in fresh milk into galacto-oligosaccharides.
[0019] Beneficial effects:
[0020] The lactase mutant T446L-R457P of the present invention has an optimum action temperature of 55°C, which is 5°C lower than that of the original enzyme. When applied to fresh milk, the residual lactose can be significantly reduced to 17.84g / L, which meets the relevant regulations of low-lactose products (lactose is less than 2g / 100g); the total lactose bioconversion rate is 82.16%, which is 10.94% higher than that of the original enzyme (74.06%), and about 31.17g / L of oligosaccharides are generated, which can efficiently convert the lactose in the fresh milk into oligosaccharide prebiotics, and the enzyme activity can be inactivated by subsequent high-temperature treatment (such as pasteurization). After incubation at 62.8°C for 10 minutes, T446L-R457P completely loses its enzyme activity, while the original enzyme still retains about 50% of its enzyme activity after 30 minutes. Description of the drawings:
[0021] Figure 1 Comparison of the spatial structure of the original enzyme BcBG168-D and the proposed mutant T446L-R457P
[0022] Among them, Figure A shows the formation of hydrogen bonds between the T446 and R457 sites in the original enzyme and the adjacent amino acid residues; Figure B shows the formation of hydrogen bonds between the L446 and P457 sites in the proposed mutant T446L-R457P and the adjacent amino acid residues; the red stick structure represents the amino acid residue at the 446 site, and the green stick structure represents the amino acid residue that forms hydrogen bonds with it; the blue stick structure represents the amino acid residue at the 457 site, and the brown stick structure represents the amino acid residue that forms hydrogen bonds with it; the yellow dotted line represents the hydrogen bond.
[0023] Figure 2 The optimal temperature for lactase
[0024] Among them, ◆: mutant T446L-R457P; ○: original lactase.
[0025] Figure 3 Heat inactivation of enzymes under pasteurization conditions
[0026] Among them, ◆: mutant T446L-R457P; ○: original lactase.
[0027] Figure 4The lactase mutant catalyzes the formation of galacto-oligosaccharides from lactose in milk
[0028] Among them, Figure A is the HPLC sugar spectrum of products with different polymerization degrees, the blue line (lower side) is the sugar spectrum of the original enzyme (BcBG168-D), and the orange line (upper side) is the sugar spectrum of the mutant T446L-R457P, DP2: disaccharide, DP3: glucosylgalactobiose or galactotriose; DP4: glucosylgalactotriose or galactotetraose; DP5: glucosylgalactotetraose or galactopentaose; Figure B is the HPLC sugar spectrum of DP2 in Figure A, 1: galactobiose, 2: lactose, 3: allolactose. Specific implementation method:
[0029] In order to make the purpose, technical solution and advantages of this patent more clear, this patent is further described in detail in combination with specific embodiments. It should be understood that the specific embodiments described here are only used to explain this patent and are not used to limit the present invention.
[0030] The starting (original) lactase molecule used in the present invention is lactase BcBG168-D, and the nucleotide sequence of its encoding gene and the corresponding amino acid sequence are shown in SEQ ID NO.1 and SEQ ID NO.2 respectively.
[0031] The coding gene for the lactase mutant of the present invention is a nucleotide sequence with a specific codon change obtained by chemical synthesis.
[0032] The method for directional screening of lactase mutants of the present invention comprises the following steps: cloning the coding gene of the lactase mutant into the expression vector pHY-WZX (Niu DD, Wang ZX. Development of a pair of bifunctional expression vectors for Escherichia coli and Bacillus licheniformis. J Ind Microbiol Biotechnol (2007) 34: 357-362. DOI 10.1007 / s10295-0204-x), genetically transforming it into the Bacillus licheniformis strain BCBT0529 (Chinese invention patent, ZL202011051056.1) to obtain a lactase-producing recombinant bacterium; preparing an enzyme solution by shake flask fermentation and purifying it, comparing and analyzing the optimum temperature, and comparing it with the original lactase (BcBG168-D), and directional screening a mutant with a lower optimum temperature.
[0033] The following definitions are used in the present invention:
[0034] 1. Nomenclature of amino acid and DNA sequences
[0035] The generally accepted IUPAC nomenclature for amino acid residues is used, either in three-letter code or in single-letter form. The generally accepted IUPAC nomenclature for DNA nucleic acid sequences is used.
[0036] 2. Identification of lactase mutants
[0037] The mutated amino acid in the lactase mutant is represented by "original amino acid + position + replaced amino acid". For example, Thr446Leu (T446L) means that the amino acid at position 446 is replaced by Leu from Thr of the original lactase; Arg457Pro (R457P) means that the amino acid at position 457 is replaced by Pro from Arg of the original lactase, and the position number corresponds to the amino acid sequence number of the original lactase in SEQ ID NO.2.
[0038] The original lactase (BcBG168-D) involved in the present invention has the amino acid sequence shown in SEQ ID NO.2: MKSTTSAAGKSVSYNDGERRVNFENWRFQRETNGSIAGAQNPGFDDSSWRKLNLPHEWSIDLDFNKNSLATHEGGYLDGGIGWNRKTFTIPESMKGKRFSLDFDGVYMNSTTYLNGEVLGTYPFGYNAFSYDISDKLYKDGRANVLVVKVNTNQPSGRWYSGSSIYRNVYLTVTDPIHVARYGTFVTTPNLEKSIKEDRDAVNIKTKISNAEAKQVKIAIKSTIYDGAGNTVQTVETEEKTAAAGTVTPFEQNTVIKQPKLWSIDKPYRYNLVTEVIVGGQTVDTYETKFGVRYFKFDENEGYSLNGEFMKLHGVSMHHDLAGGAALTNARGVERQMQIMKDVGVNAIRVTHNPASPELGLEFAANKLLIIEEAFDSWAQSKKPYDYGRFFNAWAEHDIKEMVDRGKNEPAIIMWSIGNEIYDTTNAAGVETARNLVGWVKEIDTTPRATIGEDKTRGDNVTPINSYIKEIFNIVDVVGLNYSENNYDGYHKQNPSWKLYGSETSSATRSRGVYTHPYQYNHDTKYADLQQSSYDNDYVGWGRTAQDAWKYDRDLKHIAGQFIWTGFDYIGEPTPYYNSYPAKSSYFGAVDTAGFPKDIFYYYQSQWKKEPMVHLLPHWNWKEGEKVRVLAYTNASKVELVLNGESLGNEKYDNKQTSWGAPYKETKDGKTYLEWAVPFKPGKLEAVAKDENGKVIARDQVVTAGEPASVRLTADRKVVKADGTDLSFITADIVDSKGIVVPDADHLITFNVTGQGELAGVDNGNASSVERYKDNKRKAFSGKALAIVQSSKLSGKITVHASVAGLSSDSTSVFTVTPAD。
[0039] The lactase mutant T446V-R457P of the present invention has an amino acid sequence as shown in SEQ ID NO.4:
[0040] The main experimental methods used in the present invention are as follows:
[0041] 1. Gene cloning, molecular evolution and construction of expression plasmids
[0042] Conventional molecular cloning operations are performed according to the reference method (Sambrook et al. Molecular Cloning: A Laboratory Manual, 1989). The gene encoding lactase or its mutant is used as the target gene in the present invention; the expression vector pHY-WZX is a prior art (Wang Zhengxiang, Niu Dandan. Chinese invention patent, ZL200510051648; its construction method has been disclosed in Niu DD, Wang ZX. Development of a pair of bifunctional expression vectors for Escherichia coli and Bacillus licheniformis. J Ind Microbiol Biotechnol (2007) 34: 357-362. DOI 10.1007 / s10295-0204-x.). The gene encoding lactase or its mutant is amplified by PCR and cloned into the expression vector pHY-WZX to obtain a recombinant plasmid expressing lactase.
[0043] 2. Extraction of plasmid DNA
[0044] Plasmid DNA was extracted using a plasmid extraction kit from Sigma after cell walls were lysed with a certain concentration of lysozyme.
[0045] 3. Gene amplification
[0046] DNA amplification was performed in 0.2 mL PCR thin-wall tubes. PCR amplification conditions were: 1× (95°C 5 min); 30× (94°C 10 s, 58°C 30 s, 72°C 30-300 s); 1× (72°C 10 min). The extension temperature and time of the PCR reaction varied depending on the amplification length. Unless otherwise specified, all PCR reactions were performed using Pfu DNA polymerase.
[0047] 4. Overlap PCR
[0048] Refer to the literature (Krishnan, et al. Direct and crossover PCR amplification to facilitate Tn5supF-based sequencing of lambda phage clones. Nucleic Acids Research, 1991, 22: 6177-82). The general steps are: using primers (P1+PA; PB+P2, primers PA and PB are reverse complementary sequences) of fragment up and fragment dn to mediate PCR amplification to obtain gene fragments; gel recovery and purification of amplified fragments up and dn; diluting the purified two fragments up and dn by appropriate multiples, mixing them at a molar ratio of 1:1 as templates, and using primers P1 and P2 to mediate a new PCR reaction to obtain the full-length sequence.
[0049] 5. Genetic transformation of Bacillus licheniformis
[0050] The main steps are as follows: inoculate a fresh single colony into liquid LB medium, culture overnight at 37°C 200r / min, transfer 5% of the bacterial solution to new LB medium and continue to culture until OD 600 0.75-0.90. After the bacteria were ice-bathed for 10 minutes, centrifuged at 4°C and 6000r / min for 10 minutes to collect the bacteria. Wash the cells repeatedly 4 times with pre-cooled electrotransfer washing solution (0.5mol / L sorbitol, 0.5mol / L mannitol and 10% glycerol). Suspend the cell pellet in 1mL pre-cooled electrotransfer washing solution to complete the preparation of competent cells. Take 1μL of plasmid DNA and about 100μL of competent cells and mix them, immediately electroshock (1800v, 5ms), then add electrotransfer recovery solution (LB medium containing 0.65mol / L sorbitol and 0.45mol / L mannitol), and then apply the corresponding resistance LB plate after recovery at 37°C and 160r / min, and culture at a suitable 37°C until a single colony grows. The correct transformant was verified by colony PCR verification, plasmid extraction and enzyme digestion, and fermentation verification function.
[0051] 6. Preparation of lactase and its mutants
[0052] Shake flask fermentation to produce lactase: 50 mL of fermentation medium (0.5-1.5% soybean meal, 0.5-1.2% cottonseed meal, 1-8% glucose, 0.1-0.5% ammonium sulfate; pH 7.0) is placed in a 250 mL triangular flask, inoculated with recombinant bacteria, and cultured at 30-45° C. and 120-270 r / min for 3-5 days. After the fermentation is completed, centrifuge at 6000 r / min for 10 minutes to take the supernatant, precipitate with 50%-60% saturated ammonium sulfate, and purify the enzyme protein with a Sephadex G-200 column, etc. The enzyme active component is freeze-dried for later use.
[0053] 7. Lactase activity assay
[0054] The enzyme activity of lactase is defined as: the amount of enzyme required to decompose lactose into 1 micromole of glucose per minute in 1 mL of liquid enzyme (or 1 g of solid enzyme powder) at a certain pH and temperature (pH 5.0 and temperature 40°C if not otherwise specified), which is defined as one enzyme activity unit (U) and expressed in U / mL or U / g.
[0055] Lactase activity determination: Lactose is used as substrate, and 1 mL of reaction system is used for enzyme activity determination related reactions at pH 5.0 and 40°C. 900 μL of 10% (w / v) lactose solution is placed in a centrifuge tube, preheated at 40°C for 5 min, 100 μL of diluted enzyme solution to be tested is added, timing is immediately started, the solution is shaken well, and the reaction is allowed to proceed for 20 min. The reaction is terminated in boiling water for 5 min, and the solution is cooled on ice. The glucose content is determined using a biosensor.
[0056] X=P*10*10*n / (180*t)
[0057] in:
[0058] X: enzyme activity of the original enzyme, U / mL;
[0059] P: data displayed by the biosensor, mg / 100mL;
[0060] 10: Coefficient for converting the biosensor reading into μg / mL;
[0061] 10: Volume of reaction system / 0.1mL of absorbed enzyme sample, calculated as 1mL;
[0062] n: enzyme sample dilution multiple;
[0063] 180: molecular weight of glucose;
[0064] t: reaction time, min.
[0065] 8. Conversion and product analysis of lactose in milk
[0066] To simulate the efficiency of lactase in converting lactose, 5U / g to 30U / g of lactase was added to fresh milk. The reaction was carried out at 30℃ to 60℃, and samples were taken at regular intervals.
[0067] The reaction raw materials and the formation and content of oligogalactose were analyzed by HPLC. The characteristics and generation of the enzymatic products were analyzed by double column method. The conditions for the double column method were as follows: the degree of polymerization of the product was analyzed, the mobile phase was high-purity water, the flow rate was 0.5 mL / min; Sugar-Pak TMⅠ Column (6.5×300mm) chromatographic column, column temperature 80℃, differential detector; for analysis of disaccharides, the mobile phase is 70% by volume acetonitrile, the flow rate is 1.0mL / min, YMC-Pack NH2 (250×4.6mm, 7μm) chromatographic column, column temperature 35℃, differential detector.
[0068] 9. Other analysis methods
[0069] Gene and amino acid sequence alignments were performed using DNAMAN software;
[0070] The enzyme protein content was determined according to the literature method (Bradford. Anal Chem, 1976);
[0071] Glucose content was determined by enzyme electrode method (SBA-90, Shandong);
[0072] The cell density was measured at 600 nm using a spectrophotometer (UV-2000, USA);
[0073] The present invention will be further explained below through specific examples.
[0074] Example 1: Acquisition of new lactase molecules
[0075] The present invention is based on the structural characteristics of lactase BcBG168-D. The T446 and R457 sites are located in the loop region of lactase. The loop region is an irregular curled morphology and usually has great flexibility. Mutations usually affect the steric stability of the enzyme, thereby affecting the heat resistance of lactase. Figure 1 Figure A shows that T446 in lactase BcBG168-D forms two hydrogen bonds with the spatially adjacent D444, and R457 forms three hydrogen bonds with the adjacent D454; Figure 1 In the proposed mutant T446L-R457P, L446 forms one hydrogen bond with the adjacent D444, and P457 does not form a hydrogen bond with the adjacent amino acid residue. Compared with BcBG168-D, the number of hydrogen bonds and amino acid residues formed at the L446 and P457 sites in the mutant T446L-R457P is reduced, which will reduce the stability of the local structure of lactase and change the intermolecular force. Based on this, the present invention combines T446L and R457P to obtain a new enzyme molecule T446L-R457P, whose full-length amino acid sequence is shown in SEQ ID NO.4, and the encoding gene is shown in SEQ ID NO.3.
[0076] Example 2: Preparation of mutants
[0077] The full-length sequence of the coding gene of the mutant T446L-R457P proposed in Example 1 (SEQ ID NO.3) was commissioned to Sangon Biotechnology Co., Ltd. for synthesis and cloned into the expression plasmid pHY-WZX to obtain the lactase expression plasmid pHY-T446L-R457P. According to the Bacillus licheniformis genetic transformation method described above, the recombinant plasmid pHY-T446L-R457P was transformed into Bacillus licheniformis BCBT0529 to obtain the corresponding recombinant bacteria BCB-T446L-R457P.
[0078] The above-mentioned recombinant bacteria were inoculated in a 250mL triangular flask equipped with 50mL fermentation medium (1.5% soybean meal, 1.0% cottonseed meal, 8% glucose, 0.3% ammonium sulfate, pH 7.0), with an inoculum size of 10%, and cultured on a shaking table at 37°C and 220r / min for 5 days. After the fermentation was completed, the supernatant was taken at 6000r / min for 10min and was the crude enzyme solution. The crude enzyme solution obtained was subjected to graded precipitation through 50% to 60% saturated ammonium sulfate, and the enzyme protein was further purified by a protein chromatography purification system AKTA system using a Sephadex G-200 chromatographic column, and the enzyme active component was used after sterilization through a 0.22 micron sterile filter membrane.
[0079] At the same time, the original lactase BcBG168-D was prepared by the same method as above.
[0080] Example 3: Enzymatic properties of lactase mutants
[0081] (1) Optimum working temperature
[0082] The lactase mutant T446L-R457P prepared and purified in Example 2 and the original lactase BcBG168-D were used to determine the effect of temperature on enzyme activity and stability. The enzyme solution was appropriately diluted, and 10% lactose was used as the substrate. The enzyme activity was determined in the range of 20 to 70°C at intervals of 5°C according to the lactase activity determination method. The highest enzyme activity was taken as 100%, and the relative enzyme activity at other temperatures was calculated to determine the optimal action temperature of the enzyme. Its optimal action temperature is Figure 2 As shown, the optimum temperature of T446L-R457P is 55°C, and it exhibits high enzyme activity between 40-60°C, and also has good enzyme activity at 20-37°C. The optimum temperature of the original lactase is 60°C.
[0083] (2) Enzyme inactivation rate under pasteurization conditions
[0084] Enzyme activity inactivation characteristics under pasteurization conditions. After the enzyme solution was incubated at 62.8°C for 10, 20, and 30 minutes, the enzyme activity was determined according to the lactase activity determination method. The enzyme activity without temperature treatment was taken as 100%, and the relative activity of the enzyme was calculated. The enzyme inactivation of mutant T446L-R457P under pasteurization conditions, such as Figure 3 As shown in Figure 2, after incubation at 62.8°C for 10 min, T446L-R457P completely lost its enzyme activity, while the original enzyme still retained about 50% of its enzyme activity after 30 min.
[0085] Example 4: The mutant can catalyze lactose in milk to galacto-oligosaccharides
[0086] The lactase mutant T446L-R457P prepared by the present invention and the original lactase BcBG168-D were added directly to the milk, respectively, and the enzyme was added according to the substrate concentration of 20 U / g (lactose dry matter), and the reaction system volume was about 50 mL. The reaction was carried out at 40° C. for 18 hours, and the samples were taken and detected by HPLC using a double chromatographic column.
[0087] Figure 4 The results of the sugar spectrum analysis of the low-lactose milk product produced above under the HPLC double-column detection conditions are shown in Table 2. Figure A is the sugar spectrum of products with different polymerization degrees, and Figure B is the sugar spectrum of disaccharide (DP2). The content of each sugar in the reaction product was calculated according to the area normalization method. The results are shown in Table 2. After the milk was catalyzed by lactase T446L-R457P, the residual lactose was 17.84g / L (about 1.8g / 100g), and the GOS production was 31.17g / L; the lactose conversion rate was 82.16%, which was 10.9% higher than that of the original enzyme. The residual lactose of the original enzyme was 25.94g / L (about 2.6g / 100g). After the T446L-R457P in-situ enzyme treatment, the lactose content in the milk has reached the relevant regulations for low-lactose dairy products (lactose <2g / 100g). After the reaction, the samples treated with T446L-R457P were heat treated by pasteurization (62.8°C, 10 min), and samples were taken to analyze the residual enzyme activity of lactase T446L-R457P, and the results showed that no enzyme activity was detected.
[0088] Table 2 The content of each sugar component in lactose converted from bovine milk by lactase mutants
[0089]
[0090] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the patent. It should be pointed out that, for ordinary technicians in this field, the above-mentioned implementation methods can also be modified, combined and improved without departing from the concept of this patent, which all belong to the protection scope of this patent. Therefore, the protection scope of this patent shall be based on the claims.
Claims
1. A lactase mutant, characterized in that: The amino acid sequence is shown in the sequence listing SEQ ID NO.
4.
2. A gene encoding the lactase mutant according to claim 1.
3. A recombinant vector or recombinant strain comprising the coding gene according to claim 2.
4. The recombinant vector according to claim 3, characterized in that The expression vector used was pHY-WZX plasmid.
5. The recombinant strain according to claim 3, characterized in that The host used was Bacillus licheniformis BCBT0529.
6. Use of the recombinant vector or recombinant strain according to claim 3 in producing the lactase mutant according to claim 1.
7. Use of the lactase mutant according to claim 1.
8. The use according to claim 7, characterized in that It is used in catalyzing lactose to produce galacto-oligosaccharides.
9. The use according to claim 7, characterized in that It is used in the production of low-lactose dairy products containing galacto-oligosaccharides.
10. The use according to claim 7, characterized in that It is used in the in-situ conversion of lactose in fresh milk into galacto-oligosaccharides.
Citation Information
Patent Citations
Modified beta-galactosidase
CN105765067A
Beta-galactosidase and gene, vector and strain thereof, product with enzyme and method for converting lactose and fructose into lactulose
CN108220308A
Special enzyme for galactooligosaccharide production as well as preparation and application thereof
CN112574977A
MODIFIED ß-GALACTOSIDASE
US20160251689A1
Cited By
Heat-resistant lactase mutant and application thereof in synthesis of galactooligosaccharide
CN121852355A
Heat-resistant lactase mutant and application thereof in synthesis of galacto-oligosaccharide
CN121852355B
